Literature DB >> 9638121

Hypertension care at a Cape Town community health centre.

D W Lunt1, P R Edwards, K Steyn, C J Lombard, G S Fehrsen.   

Abstract

OBJECTIVES: To describe the demographic profile of hypertensive patients and the quality of care for hypertension at a Cape Town community health centre (CHC).
DESIGN: Prospective, descriptive study. SETTING AND
SUBJECTS: Medium-sized CHC, attended by 1,098 hypertensive patients during a 1-year period from 1 January 1992. OUTCOME MEASURES: Default rate--proportion of due visits not attended. Loss to follow-up--proportion of patients persistently defaulting or not responding to recall. Frequency of blood pressure measurement--per 12 due visits. Compliance--proportion of patients collecting > or = 75% of antihypertensive drugs. Blood pressure control--mean blood pressure of aggregated readings; and proportion controlled (< 160/95 mmHg) on the basis of all blood pressure readings and mean blood pressures of individual patients with two or more readings during the study period.
RESULTS: More than half (51.6%) of the hypertensive patients were aged > or = 65 years; 81.7% were female. The default rate was between 11.9% and 19.4%. Compliance was high (76.9%). Loss to follow-up was 8.1%. Blood pressure was recorded a mean of 4.0 times per 12 due visits. There were no significant gender differences with regard to these measures. Mean blood pressure was 158.3/89.6 mmHg. Over half (56.7%) of all individual readings over the year were uncontrolled and 51.4% of patients were found to be uncontrolled when categorised by their mean blood pressure. Control was significantly poorer among women > or = 65 years.
CONCLUSION: We found better compliance, more frequent blood pressure measurement, and lower defaulting and loss to follow-up compared with previous South African studies in similar settings. Despite this, blood pressure control was mediocre. Possible explanations for this are discussed. The low proportion of male hypertensives attending the CHC suggests that the accessibility or acceptability of care is poor for this group. The study illustrates the potential for research in this setting and for the use of computers to monitor the quality of primary care.

Entities:  

Mesh:

Year:  1998        PMID: 9638121

Source DB:  PubMed          Journal:  S Afr Med J


  7 in total

1.  A comparison of two methods for measuring anti-hypertensive drug use: concordance of use with South African standard treatment guidelines.

Authors:  Thamizhanban Pillay; Anthony J Smith; Suzanne R Hill
Journal:  Bull World Health Organ       Date:  2009-06       Impact factor: 9.408

Review 2.  A systematic review of adherence to cardiovascular medications in resource-limited settings.

Authors:  Ashna D K Bowry; William H Shrank; Joy L Lee; Margaret Stedman; Niteesh K Choudhry
Journal:  J Gen Intern Med       Date:  2011-08-20       Impact factor: 5.128

3.  Dismal management of hypertension at primary level: does it reflect a failure of patients, a failure of the system or a failure of doctors?

Authors:  N B A Ntusi
Journal:  Cardiovasc J Afr       Date:  2011 Jul-Aug       Impact factor: 1.167

4.  Health practitioners' state of knowledge and challenges to effective management of hypertension at primary level.

Authors:  A Parker; B Nagar; G Thomas; M Badri; N B A Ntusi
Journal:  Cardiovasc J Afr       Date:  2011 Jul-Aug       Impact factor: 1.167

Review 5.  A systematic overview of prospective cohort studies of cardiovascular disease in sub-Saharan Africa.

Authors:  Andre Pascal Kengne; Lucas M Ntyintyane; Bongani M Mayosi
Journal:  Cardiovasc J Afr       Date:  2011-09-07       Impact factor: 1.167

6.  Awareness of hypertension and factors associated with uncontrolled hypertension in Sudanese adults.

Authors:  Fawzi A Babiker; Lamia A Elkhalifa; Mohamed E Moukhyer
Journal:  Cardiovasc J Afr       Date:  2013-07       Impact factor: 1.167

7.  Factors Associated with Medication Nonadherence among Hypertensives in Ghana and Nigeria.

Authors:  Vincent Boima; Adebowale Dele Ademola; Aina Olufemi Odusola; Francis Agyekum; Chibuike Eze Nwafor; Helen Cole; Babatunde L Salako; Gbenga Ogedegbe; Bamidele O Tayo
Journal:  Int J Hypertens       Date:  2015-10-05       Impact factor: 2.420

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.